跳到正文
原文
STAT 主站· Tara Bannow·· 2026-10-10AI 评分58

美国医院协会再起诉特朗普政府,寻求叫停扩大版 340B 返利试点

STAT+: Hospitals sue – again – to halt Trump administration’s 340B rebate pilot

AI 导读

美国医院协会(AHA)再次起诉特朗普政府,寻求叫停定于2027年1月1日生效的扩大版 340B 返利试点。新试点覆盖 Medicare 下25种最昂贵、使用最广泛的药物,原计划仅涉及10种;AHA 认为政府未准确核算医院先按市场价购药再申请返利所增加的成本。

正文

The American Hospital Association is once again suing the Trump administration over its plan to test revamping a federal drug discount program into one that provides after-the-fact rebates instead of upfront discounts for certain drugs. 

It’s the second time the powerful hospital lobbying group has sued over such a plan. The first time, in 2025, a judge agreed to temporarily halt a more limited version from taking effect, and the Health and Human Services Department voluntarily withdrew the plan after losing on appeal. In February, the agency announced an expanded version, set to take effect Jan. 1, 2027, that would target 25 of the costliest, most widely used drugs covered under Medicare. The original plan included 10 drugs. 

The AHA’s argument is largely the same as in the first case: the government failed to accurately account for the costs hospitals would incur by having to pay market prices for drugs and then apply for rebates. The lawsuit says that the Health Resources and Services Administration, the HHS division that administers 340B, received more than 2,400 comments on the rebate model’s second iteration, including hospitals describing in “granular detail the catastrophic impact” it would have. 

Continue to STAT+ to read the full story…

来源:STAT 主站 · statnews.com